Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Myeloma Knowledge Exchange 2018 /
Treating bone disease in multiple myeloma patients

27th - 28th Apr 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 02.05.18
Views: 1902

Dr John Ashcroft - Mid Yorkshire Hospitals NHS Trust, Wakefield, UK

Dr Ashcroft speaks with ecancer at the 2018 Myeloma Knowledge Exchange about the treatment of bone disease in multiple myeloma patients.

He outlines the potential new drugs such as denosumab, as well as the history and changes of bone disease treatments.

Dr Ashcroft also touches on the promising use of anabolic agents as a preventative measure in combination with anti-catabolic agents.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation